AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33975490 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CPAP and Sham CPAP
Number of subjects: 47
Study 32859328 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein (CRHP) diet
Number of subjects: 16
Study 32859328 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes (CD) diet
Number of subjects: 16
Study 36380601 — intervention group
Group type: EXPERIMENTAL
Intervention: EVERYbody Project
Number of subjects: 90
Study 36380601 — intervention group
Group type: COMPARATOR
Intervention: Video-based, low-dissonance comparison intervention
Number of subjects: 90
Study 34229862 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine 0.25% plus normal saline
Number of subjects: 70
Study 34229862 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25% plus dexmedetomidine 1 μg.kg‐1
Number of subjects: 70
Study 32998517 — intervention group
Group type: EXPERIMENTAL
Intervention: U-13C18:0 (stearate)
Number of subjects: 6
Study 32998517 — intervention group
Group type: COMPARATOR
Intervention: U-13C18:1 (oleate)
Number of subjects: 6
Study 33578236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil combined with Tanshinone
Number of subjects: 58
Study 33578236 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanshinone I
Number of subjects: 58
Study 33578236 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanshinone IIA/B
Number of subjects: 58
Study 33506278 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 90
Study 33506278 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical model
Number of subjects: 90
Study 33506278 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 90
Study 32393349 — intervention group
Group type: EXPERIMENTAL
Intervention: Auxiliary nurse midwives conducting periodontal examinations
Number of subjects: 21
Study 34913825 — intervention group
Group type: EXPERIMENTAL
Intervention: Econazole 250 mg
Number of subjects: 8
Study 34913825 — intervention group
Group type: EXPERIMENTAL
Intervention: Econazole 500 mg
Number of subjects: 8
Study 34913825 — intervention group
Group type: EXPERIMENTAL
Intervention: Econazole 1000 mg
Number of subjects: 8
Study 34913825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 32456170 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity group (running for ten minutes)
Number of subjects: 51
Study 32456170 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 51
Study 35948889 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT intervention (N=85)
Number of subjects: 168
Study 35948889 — intervention group
Group type: COMPARATOR
Intervention: Usual care (N=83)
Number of subjects: 168
Study 33644986 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft-tissue mobilization therapy and 20 spinal mobility exercises
Number of subjects: 21
Study 33644986 — intervention group
Group type: COMPARATOR
Intervention: 20 spinal mobility exercises
Number of subjects: 21
Study 36250322 — intervention group
Group type: EXPERIMENTAL
Intervention: iAE group (ClassIntra grade)
Number of subjects: 528
Study 36250322 — intervention group
Group type: EXPERIMENTAL
Intervention: ClassIntra grade ≥II
Number of subjects: 528
Study 36250322 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher ClassIntra grade, lower OSATS score, total gastrectomy
Number of subjects: 528
Study 36250322 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 528
Study 32338931 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive therapy (EBCT)
Number of subjects: 149
Study 32338931 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 149
Study 32338931 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EBCT and CBT
Number of subjects: 149
Study 36367856 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario-based virtual laboratory simulation (SB-VLS) on molecular cloning
Number of subjects: 35
Study 36367856 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture and video lab demonstration (VLD)
Number of subjects: 35
Study 34491219 — intervention group
Group type: EXPERIMENTAL
Intervention: Children teaching parents using a booklet
Number of subjects: 142
Study 34491219 — intervention group
Group type: EXPERIMENTAL
Intervention: Children teaching parents without a booklet
Number of subjects: 142
Study 34491219 — intervention group
Group type: COMPARATOR
Intervention: Children listening to an unrelated topic
Number of subjects: 142
Study 34491219 — intervention group
Group type: COMPARATOR
Intervention: Parents learning from an expert
Number of subjects: 142
Study 34491219 — intervention group
Group type: COMPARATOR
Intervention: Parents learning about an unrelated topic
Number of subjects: 142
Study 32811734 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimodal therapy consisting of 2% Nitroglycerine (NTG), Hyperbaric Oxygen Therapy (HBOT), and local steroids
Number of subjects: 82
Study 32811734 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerine (NTG) and local steroids (without HBOT)
Number of subjects: 82
Study 36454883 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-face-to-face (NFF) CPR training
Number of subjects: 70
Study 36454883 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face (FF) CPR training
Number of subjects: 70
Study 34794222 — intervention group
Group type: EXPERIMENTAL
Intervention: MALDI‐TOF MS combined with magnetic bead technology
Number of subjects: 54
Study 34794222 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant serglycin (SRGN) and fibrinogen alpha chain (FGA)
Number of subjects: 54
Study 34794222 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 54
Study 36309759 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg oral bosentan, twice a day for 8 weeks
Number of subjects: 86
Study 36309759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 33627329 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion (standard management)
Number of subjects: 58
Study 33627329 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% dextrose) infusion (restrictive management)
Number of subjects: 58
Study 33627329 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard management
Number of subjects: 58
Study 33627329 — intervention group
Group type: COMPARATOR
Intervention: Restrictive management
Number of subjects: 58
Study 35648267 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow withdrawal (160 days)
Number of subjects: 48
Study 35648267 — intervention group
Group type: COMPARATOR
Intervention: Rapid withdrawal (60 days)
Number of subjects: 48
Study 34044534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic peptide inhibitors of FXIIa
Number of subjects: 0
Study 32199006 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic proportional minute ventilation (APMV)
Number of subjects: 80
Study 32199006 — intervention group
Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV‐p) or pressure control modes (PCV) without APMV
Number of subjects: 80
Study 33287553 — intervention group
Group type: EXPERIMENTAL
Intervention: Singapore Physical Activity and Nutrition Study (SPANS) intervention group
Number of subjects: 580
Study 34919634 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 39
Study 34919634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 33124895 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Levilactobacillus brevis CECT7480 and Lactoplantibacillus plantarum CECT7481), 2 tablets per day for 1 week
Number of subjects: 38
Study 33124895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 34639746 — intervention group
Group type: EXPERIMENTAL
Intervention: CPSCoD training (twice weekly for 8 weeks)
Number of subjects: 17
Study 32417773 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension (SBP≥140 mmHg) in age group 60-69
Number of subjects: 488
Study 32417773 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension (SBP≥140 mmHg) and WMH in age group 50-59
Number of subjects: 488
Study 32417773 — intervention group
Group type: EXPERIMENTAL
Intervention: WMH in age group ≥70
Number of subjects: 488
Study 32417773 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension and WMH across age bands
Number of subjects: 488
Study 36045965 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide combined with loratadine
Number of subjects: 120
Study 36045965 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate nasal spray combined with loratadine
Number of subjects: 120
Study 32885676 — intervention group
Group type: EXPERIMENTAL
Intervention: High threat message with seeking cue
Number of subjects: 1823
Study 32885676 — intervention group
Group type: EXPERIMENTAL
Intervention: High threat message without seeking cue
Number of subjects: 1823
Study 32885676 — intervention group
Group type: EXPERIMENTAL
Intervention: Low threat message with seeking cue
Number of subjects: 1823
Study 32885676 — intervention group
Group type: EXPERIMENTAL
Intervention: Low threat message without seeking cue
Number of subjects: 1823
Study 32885676 — intervention group
Group type: EXPERIMENTAL
Intervention: No message with seeking cue
Number of subjects: 1823
Study 32885676 — intervention group
Group type: EXPERIMENTAL
Intervention: No message without seeking cue
Number of subjects: 1823
Study 32885676 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 1823
Study 35584341 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial valves (BLVR)
Number of subjects: 24
Study 33259771 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic mesh
Number of subjects: 87
Study 33259771 — intervention group
Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 87
Study 34417367 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐CME
Number of subjects: 93
Study 34417367 — intervention group
Group type: COMPARATOR
Intervention: s‐CME
Number of subjects: 93
Study 33474945 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized response technique (RRT)
Number of subjects: 0
Study 33474945 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation sampling tests
Number of subjects: 0
Study 32842953 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy in acute stroke
Number of subjects: 0
Study 36096534 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg) every 4 weeks until worsening or unacceptable toxicity
Number of subjects: 19
Study 36096534 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg)
Number of subjects: 19
Study 34160450 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexic children
Number of subjects: 0
Study 34160450 — intervention group
Group type: COMPARATOR
Intervention: Non-dyslexic children
Number of subjects: 0
Study 32094127 — intervention group
Group type: EXPERIMENTAL
Intervention: IMI-REL
Number of subjects: 72
Study 32094127 — intervention group
Group type: COMPARATOR
Intervention: Colistin plus IMI
Number of subjects: 72
Study 36183101 — intervention group
Group type: COMPARATOR
Intervention: Aqueous crystalline penicillin G (ACPG)
Number of subjects: 290
Study 36183101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 290
Study 36220337 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) treatment
Number of subjects: 318
Study 33862593 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression plus fusion
Number of subjects: 608
Study 33862593 — intervention group
Group type: COMPARATOR
Intervention: Decompression alone
Number of subjects: 608
Study 35320174 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic primary repair of defect with non-absorbable suture prior to mesh placement (Group A)
Number of subjects: 100
Study 35320174 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic repair without primary closure of the defect (Group B)
Number of subjects: 100
Study 32610481 — intervention group
Group type: COMPARATOR
Intervention: e+ shot
Number of subjects: 30
Study 32610481 — intervention group
Group type: COMPARATOR
Intervention: caffeine
Number of subjects: 30
Study 32610481 — intervention group
Group type: EXPERIMENTAL
Intervention: placebo
Number of subjects: 30
Study 35304117 — intervention group
Group type: EXPERIMENTAL
Intervention: AI first colonoscopy
Number of subjects: 230
Study 35304117 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy first
Number of subjects: 230
Study 32341103 — intervention group
Group type: EXPERIMENTAL
Intervention: RAAS inhibitors
Number of subjects: 0
Study 32341103 — intervention group
Group type: EXPERIMENTAL
Intervention: RAAS modulation
Number of subjects: 0
Study 32341103 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed interventions for SARS-CoV-2
Number of subjects: 0
Study 32341103 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulation of downstream pathophysiologic effects
Number of subjects: 0
Study 32341103 — intervention group
Group type: EXPERIMENTAL
Intervention: RAAS-based interventions
Number of subjects: 0
Study 35550621 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP-based TB screening using a point-of-care (POC) assay
Number of subjects: 0
Study 35550621 — intervention group
Group type: COMPARATOR
Intervention: Symptom-based TB screening (current practice)
Number of subjects: 0
Study 34726874 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic stapedotomy
Number of subjects: 22
Study 34726874 — intervention group
Group type: COMPARATOR
Intervention: Microscopic stapedotomy
Number of subjects: 22
Study 32130328 — intervention group
Group type: EXPERIMENTAL
Intervention: OM‐85 BV
Number of subjects: 54
Study 32130328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 34890961 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassionate Mind Training (CMT) program for caregivers of RYC
Number of subjects: 85
Study 34890961 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study 34632114 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 50
Study 34632114 — intervention group
Group type: COMPARATOR
Intervention: Denosumab
Number of subjects: 50
Study 32955554 — intervention group
Group type: EXPERIMENTAL
Intervention: iCanQuit (ACT-based application)
Number of subjects: 2415
Study 32955554 — intervention group
Group type: COMPARATOR
Intervention: QuitGuide (USCPG-based application)
Number of subjects: 2415
Study 35550709 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 733
Study 32974974 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive PDT with 5-aminolevulinic acid (BF-200 ALA)
Number of subjects: 45
Study 32974974 — intervention group
Group type: COMPARATOR
Intervention: Non-occlusive PDT with 5-aminolevulinic acid (BF-200 ALA)
Number of subjects: 45
Study 34563559 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-Lyte.½
Number of subjects: 104
Study 34563559 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 104
Study 32861372 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular Stabilization (SSG) exercises
Number of subjects: 60
Study 32861372 — intervention group
Group type: COMPARATOR
Intervention: Periscapular Strengthening (PSG) exercises
Number of subjects: 60
Study 35441378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (not specified)
Number of subjects: 0
Study 35441378 — intervention group
Group type: EXPERIMENTAL
Intervention: Random intercept mixed effects linear regression
Number of subjects: 0
Study 35441378 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal allocation of units under a fixed cost
Number of subjects: 0
Study 33471144 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorelle® Y mesh
Number of subjects: 62
Study 33471144 — intervention group
Group type: COMPARATOR
Intervention: Dual flat mesh
Number of subjects: 62
Study 35914894 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving pressure-guided ventilation (DP)
Number of subjects: 78
Study 35914894 — intervention group
Group type: COMPARATOR
Intervention: Protective ventilation (PV)
Number of subjects: 78
Study 35914894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DP and PV)
Number of subjects: 78
Study 34253718 — intervention group
Group type: EXPERIMENTAL
Intervention: High SES households
Number of subjects: 0
Study 34253718 — intervention group
Group type: COMPARATOR
Intervention: Low SES households
Number of subjects: 0
Study 33655814 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal fat oxidation (MFO) during a graded exercise test
Number of subjects: 119
Study 33655814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity of exercise that elicits MFO (Fatmax) during a graded exercise test
Number of subjects: 119
Study 34105321 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based rhythmic exercise training (12 weeks, 60 min, 3 times a week)
Number of subjects: 31
Study 32415610 — intervention group
Group type: EXPERIMENTAL
Intervention: dd-cfDNA testing
Number of subjects: 175
Study 32415610 — intervention group
Group type: COMPARATOR
Intervention: No dd-cfDNA testing (Control)
Number of subjects: 175
Study 36070877 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching (5 coaching sessions biweekly, 30-45 minutes each)
Number of subjects: 94
Study 36070877 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching
Number of subjects: 94
Study 33721689 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment A (active)
Number of subjects: 38
Study 33721689 — intervention group
Group type: COMPARATOR
Intervention: Treatment B (passive)
Number of subjects: 38
Study 33028707 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation combining sound and tongue stimulation
Number of subjects: 326
Study 33663733 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1498
Study 33663733 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 1498
Study 33543227 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser-assisted method (808 nm, 1.5 W laser with fiber diameter of 320 μm for hemorrhage control and 1W laser for decontamination)
Number of subjects: 100
Study 33543227 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 100
Study 33349933 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood PAE group
Number of subjects: 83
Study 33349933 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent PAE group
Number of subjects: 83
Study 33349933 — intervention group
Group type: COMPARATOR
Intervention: Adolescent control group
Number of subjects: 83
Study 33349933 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood PAE group at 4-year follow-up
Number of subjects: 83
Study 32517492 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D fluoroscopy
Number of subjects: 100
Study 32517492 — intervention group
Group type: COMPARATOR
Intervention: 2D fluoroscopy
Number of subjects: 100
Study 36172728 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen therapy (HFNO)
Number of subjects: 180
Study 36172728 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV)
Number of subjects: 180
Study 36172728 — intervention group
Group type: COMPARATOR
Intervention: Nasal oxygen breath (NOB)
Number of subjects: 180
Study 34381706 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 853
Study 34381706 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 853
Study 32366450 — intervention group
Group type: EXPERIMENTAL
Intervention: High tie of the inferior mesenteric artery (IMA)
Number of subjects: 56
Study 32366450 — intervention group
Group type: COMPARATOR
Intervention: Low tie of the inferior mesenteric artery (IMA)
Number of subjects: 56
Study 36082663 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan 200 mg twice daily
Number of subjects: 544
Study 36082663 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 5 mg twice daily
Number of subjects: 544
Study 32331024 — intervention group
Group type: EXPERIMENTAL
Intervention: AMPH ER TAB 20 mg swallowed (fasted)
Number of subjects: 32
Study 32331024 — intervention group
Group type: EXPERIMENTAL
Intervention: AMPH ER TAB 20 mg chewed (fed/fasted)
Number of subjects: 32
Study 32331024 — intervention group
Group type: COMPARATOR
Intervention: AMPH EROS 20 mg fasted
Number of subjects: 32
Study 32331024 — intervention group
Group type: EXPERIMENTAL
Intervention: AMPH ER TAB chewed (fasted) vs. fed
Number of subjects: 32
Study 35559521 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine Nitrate (CN: 5 g/day + 0.675 g/day of maltodextrin)
Number of subjects: 12
Study 35559521 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF: 400 mg/day + 5 g/day of maltodextrin)
Number of subjects: 12
Study 35559521 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine Nitrate + Caffeine (CN+CAF: 5 g/day of creatine nitrate + 400 mg/day of caffeine)
Number of subjects: 12
Study 35559521 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL: 5.4 g/day of maltodextrin)
Number of subjects: 12
Study 32024498 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonized water (group 1)
Number of subjects: 20
Study 32024498 — intervention group
Group type: COMPARATOR
Intervention: Double distilled water (group 2)
Number of subjects: 20
Study 33927343 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective progesterone receptor modulator (SPRM)
Number of subjects: 30
Study 33927343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35162512 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Skills Group Training (SSGT)
Number of subjects: 20
Study 35162512 — intervention group
Group type: COMPARATOR
Intervention: Active social control activities
Number of subjects: 20
Study 33235172 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact aspiration
Number of subjects: 20
Study 33235172 — intervention group
Group type: COMPARATOR
Intervention: Stent retriever
Number of subjects: 20
Study 35346329 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-session group advocacy training intervention
Number of subjects: 0
Study 35346329 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 0